Phosphodiesterase Inhibitor‐Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 Palliation

Phosphodiesterase Inhibitor‐Based Vasodilation Improves Oxygen Delivery and Clinical Outcomes Following Stage 1 Palliation

BackgroundSystemic vasodilation using α‐receptor blockade has been shown to decrease the incidence of postoperative cardiac arrest following stage 1 palliation (S1P), primarily when utilizing the modified Blalock‐Taussig shunt. We studied the effects of a protocol in which milrinone was primarily us...

Full description

Bibliographic Details
Main Authors: Kimberly I. Mills, Aditya K. Kaza, Brian K. Walsh, Hilary C. Bond, Mackenzie Ford, David Wypij, Ravi R. Thiagarajan, Melvin C. Almodovar, Luis G. Quinonez, Christopher W. Baird, Sitaram E. Emani, Frank A. Pigula, James A. DiNardo, John N. Kheir
Format: Article
Language:English
Published: Wiley 2016-10-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
hypoplastic left heart syndrome
hypoxia
oxygen
oxygen consumption
phosphodiesterase inhibitor
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.116.003554

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.116.003554

Similar Items